We are live on ! Find out more
TSW

Thompson Siegel & Walmsley Portfolio holdings

AUM $5.7B
1-Year Est. Return 6.69%
This Fund
S&P 500
This Quarter Est. Return
+4.56%
1 Year Est. Return
+6.69%
3 Year Est. Return
+28.78%
5 Year Est. Return
+35.85%
10 Year Est. Return
+92.81%
AUM
$5.16B
AUM Growth
+$203M
Cap. Flow
+$40.2M
Cap. Flow %
0.78%
Top 10 Hldgs %
18.41%
Holding
695
New
34
Increased
113
Reduced
198
Closed
43

Top Buys

Rank Stock Value
1
LBTYK icon
Liberty Global Class C
LBTYK
+$94.2M
2
SEE
Sealed Air
SEE
+$42.4M
3
AXTA icon
Axalta
AXTA
+$32.7M
4
ACM icon
Aecom
ACM
+$29.1M
5
NI icon
NiSource
NI
+$28.7M

Top Sells

Rank Stock Value
1
ZBH icon
Zimmer Biomet
ZBH
+$41.6M
2
MOS icon
The Mosaic Company
MOS
+$34.9M
3
LH icon
Labcorp
LH
+$27.7M
4
DELL icon
Dell
DELL
+$26.2M
5
ANET icon
Arista Networks
ANET
+$24.9M

Sector Composition

Rank Sector Weight
1 Financials 14.34%
2 Technology 11.69%
3 Communication Services 10.47%
4 Utilities 10.22%
5 Healthcare 9.88%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CDNA icon
401
CareDx
CDNA
$2.35B
$66K ﹤0.01%
1,745
MAR icon
402
Marriott International
MAR
$94.2B
$65K ﹤0.01%
706
-2,000
-74% -$189K
DLA
403
DELISTED
Delta Apparel Inc.
DLA
$65K ﹤0.01%
4,569
RDS.A
404
DELISTED
Royal Dutch Shell PLC ADS Class A
RDS.A
$65K ﹤0.01%
2,598
-500
-16% -$15.1K
XLF icon
405
State Street Financial Select Sector SPDR ETF
XLF
$58.6B
$64K ﹤0.01%
2,675
DWAS icon
406
Invesco Dorsey Wright SmallCap Momentum ETF
DWAS
$450M
$63K ﹤0.01%
1,065
ENB icon
407
Enbridge
ENB
$113B
$63K ﹤0.01%
2,164
WAB icon
408
Wabtec
WAB
$50B
$63K ﹤0.01%
1,011
-251,914
-100% -$16.2M
ZBH icon
409
Zimmer Biomet
ZBH
$19B
$63K ﹤0.01%
477
-318,588
-100% -$41.6M
BABA icon
410
Alibaba
BABA
$308B
$61K ﹤0.01%
207
LBRDK icon
411
Liberty Broadband Class C
LBRDK
$5.16B
$61K ﹤0.01%
430
PANW icon
412
Palo Alto Networks
PANW
$296B
$61K ﹤0.01%
1,500
-30
-2% -$1.25K
APD icon
413
Air Products & Chemicals
APD
$65.7B
$60K ﹤0.01%
201
-13
-6% -$3.74K
VCEL icon
414
Vericel Corp
VCEL
$2.32B
$60K ﹤0.01%
3,230
ELV icon
415
Elevance Health
ELV
$84.8B
$59K ﹤0.01%
220
PFNX
416
DELISTED
Pfenex Inc.
PFNX
$59K ﹤0.01%
4,629
BLK icon
417
Blackrock
BLK
$176B
$58K ﹤0.01%
103
-2
-2% -$1.14K
WTRG icon
418
Essential Utilities
WTRG
$11.2B
$58K ﹤0.01%
1,444
BATRA icon
419
Atlanta Braves Holdings Series A
BATRA
$3.39B
$56K ﹤0.01%
2,696
KLIC icon
420
Kulicke & Soffa
KLIC
$4.91B
$56K ﹤0.01%
2,500
GILD icon
421
Gilead Sciences
GILD
$164B
$55K ﹤0.01%
873
-7,344
-89% -$509K
WPC icon
422
W.P. Carey
WPC
$16.4B
$52K ﹤0.01%
817
AZN icon
423
AstraZeneca
AZN
$250B
$51K ﹤0.01%
464
-100
-18% -$11.1K
EPD icon
424
Enterprise Products Partners
EPD
$81.6B
$51K ﹤0.01%
3,200
MATV icon
425
Mativ Holdings
MATV
$527M
$51K ﹤0.01%
1,670

Similar funds

Thompson Siegel & Walmsley's Q3 2020 Portfolio in Review

As of Q3 2020, Thompson Siegel & Walmsley held 695 positions worth $5.16B, up 4.1% from $4.96B the previous quarter. Its ten largest holdings account for 18% of the portfolio.

Thompson Siegel & Walmsley's Q3 2020 filing shows 34 new, 113 increased, 198 reduced and 43 closed positions. Its largest new stake was Liberty Global Class C: 4,285,600 shares worth $88M. The largest sale was Zimmer Biomet, an estimated $41.6M.

By sector, the portfolio is most concentrated in Financials at 14% of assets, down from 16% a quarter earlier, followed by Technology and Communication Services.

  • Thompson Siegel & Walmsley's largest Q3 2020 buy was Liberty Global Class C: 4,285,600 shares worth $88M.
  • Thompson Siegel & Walmsley added most to Sealed Air in Q3 2020, an estimated $42.4M increase.
  • Thompson Siegel & Walmsley's biggest Q3 2020 reduction was Zimmer Biomet, cutting an estimated $41.6M.
  • Thompson Siegel & Walmsley fully exited Open Text in Q3 2020, selling an estimated $8.54M.
  • Thompson Siegel & Walmsley's ten largest holdings make up 18% of its $5.16B portfolio in Q3 2020.
  • Thompson Siegel & Walmsley opened 34 new positions and closed 43 in Q3 2020.
  • Thompson Siegel & Walmsley's portfolio value rose 4.1% quarter-over-quarter to $5.16B.

Based on Thompson Siegel & Walmsley's 13F filing for Q3 2020, filed 12 Nov 2020.